Welcome to ArizonaLifeScience.com
ArizonaLifeScience.com is part of a specialized network of state based biotechnology, medical device,
and life science sites that includes more than 3,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
More...
|
|
Learn About Arizona's BioHistory
Why is there a biotechnology industry in Arizona? Will the industry continue
to grow in Arizona? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Arizona BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Arizona.
More AZ BioHistory...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Spectrum announces sale of injectable generic drugs to Sagent Spectrum Pharmaceuticals announced that it has sold its abbreviated new drug applications for its injectable generic drugs, ondansetron, carboplatin, fludarabine, and mitoxantrone, to Sagent Pharmaceuticals.
Spectrum Pharmaceuticals, Inc. May 09, 2008
- Affymax(R) reports first quarter 2008 financial results Affymax reported financial results for the first quarter ended March 31, 2008. The net loss for the first quarter of 2008 was $15.6 million compared to a net loss of $7.2 million for the first quarter of 2007.
Affymax, Inc. May 09, 2008
- Cytori reports first Celution(R) System revenues during the first quarter Cytori Therapeutics achieves first Celution(R) System revenues in the quarter ended March 31, 2008. Cytori received orders for 13 Celution 800 Systems during the first quarter of 2008 for customers and distributors in both Europe and Asia.
Cytori Therapeutics May 09, 2008
- Ardea Biosciences appoints John W. Beck Chief Financial Officer, reports Q1 results Ardea Biosciences announced that John W. Beck has been appointed Senior Vice President, Finance and Operations and Chief Financial Officer effective May 27, 2008. The Company also reported recent accomplishments and financial results for the first quarter ended March 31, 2008.
Ardea Biosciences, Inc. May 09, 2008
- Napo presents at ISPOR Meeting in Toronto Napo Pharmaceuticals announces that it presented a poster in collaboration with QualityMetric describing the development of a patient reported outcomes questionnaire focused on the Health-Related Quality of Life (HR-QoL) aspects of chronic diarrhea in persons living with HIV/AIDS.
Napo Pharmaceuticals, Inc. May 09, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
Upcoming Events...
More... |
Submit Event |
Event Advertising...
|
Deutsch |
Español |
Français |
Norsk |
Russian
|